Klaus Kopka

机构：German Cancer Research Center, Heidelberg University, Helmholtz-Zentrum Dresden-Rossendorf, German Cancer Society, National Center for Tumor Diseases, University Hospital Carl Gustav Carus, Hochschule für Technik und Wirtschaft Dresden – University of Applied Sciences, Nationales Centrum für Tumorerkrankungen Dresden, Deutsches Konsortium für Translationale Krebsforschung, Technische Universität Dresden · ORCID：0000-0003-4846-1271

发表论文 489 篇 · 总被引 18682 次 · h-index 65

代表论文

• New prostate cancer risk groups by PSMA-PET (PPP3): an international, retrospective, registry-based cohort study (2026 · The Lancet Oncology · 被引 3)
• Novel immunotheranostic FAP-inhibitor target modules for imaging and elimination of FAP-positive cells by UniCAR T-cells (2025 · OncoImmunology · 被引 2)
• Synthesis and preclinical evaluation of FAP-targeting radiotracers for PET and optical imaging (2025 · EJNMMI Radiopharmacy and Chemistry · 被引 1)
• The Second Nitrogen Fits: Development of Diazine-Based Macrocyclic Chelators to Stably Bind Radionuclides Used in Targeted Alpha Therapy (2026 · Inorganic Chemistry)
• Data publication: "Imaging triplets on two wheels" - ⁶¹Cu-, ⁶⁴Cu-, and ⁶⁸Ga-labeled bicyclic peptides targeting Nectin-4 enable high-contrast PET imaging of urothelial carcinoma and triple-negative breast cancer (2026 · RODARE)
• Data publication: "Precision on two wheels" – Structural refinement of ⁶⁴Cu- and ⁶⁸Ga-labeled bicyclic peptides targeting nectin-4 for improved tumor imaging: from preclinical development to first-in-human application (2026 · RODARE)